Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.61 |
| ▸ | MEN1 | O00255 | 4/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.61 |
| ▸ | EGFR | P00533 | 2/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | HTT | P42858 | 2/20 | 0.61 |
| ▸ | POLB | P06746 | 2/20 | 0.61 |
| ▸ | BLM | P54132 | 2/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | RAD52 | P43351 | 1/20 | 0.61 |
| ▸ | RECQL | P46063 | 1/20 | 0.61 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.61 |
| ▸ | NSD2 | O96028 | 2/20 | 0.56 |
| ▸ | FGB | P02675 | 1/20 | 0.56 |
| ▸ | MMP14 | P50281 | 1/20 | 0.56 |
| ▸ | TERT | O14746 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 8/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32667983 | 1.00 | MAPT (0.61) | MAPTMEN1KMT2ASMN1; SMN2EGFR | |
| Hydrochloric Acid SCHEMBL8604068 | 0.99 | MAPT (0.60) | MAPTMEN1KMT2ASMN1; SMN2EGFR | |
| SCHEMBL8602072 | 0.98 | MAPT (0.63) | MAPTMEN1KMT2ASMN1; SMN2EGFR | |
| Hydrochloric Acid SCHEMBL8603274 | 0.97 | MAPT (0.61) | MAPTMEN1KMT2ASMN1; SMN2EGFR | |
| SCHEMBL6372356 | 0.95 | NSD2 (0.60) | MAPTMEN1KMT2ASMN1; SMN2EGFR | |
| SCHEMBL6366937 | 0.94 | TERT (0.57) | MAPTMEN1KMT2ASMN1; SMN2EGFR | |
| SCHEMBL20333883 | 0.94 | TERT (0.57) | MAPTMEN1KMT2ASMN1; SMN2EGFR | |
| SCHEMBL109325 | 0.94 | MEN1 (0.64) | MAPTMEN1KMT2ASMN1; SMN2EGFR | |
| SCHEMBL6368226 | 0.94 | NSD2 (0.61) | MAPTMEN1KMT2ASMN1; SMN2EGFR | |
| Hydrochloric Acid SCHEMBL6577424 | 0.93 | MAPT (0.63) | MAPTMEN1KMT2ASMN1; SMN2EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1948738-B1 | COLOURED PARTICLES FOR ELECTROPHORETIC DISPLAYS | BASF SE (DE) | 2018-02-28 | — | — | EP | disclosed |
| US-8456733-B2 | Coloured particles for electrophoretic displays | BASF SE (DE) | 2013-06-04 | — | — | US | disclosed |
| US-8456733-B2 | Coloured particles for electrophoretic displays | BASF SE (DE) | 2013-06-04 | — | — | US | disclosed |
| US-7947848-B2 | Coloured silsesquioxanes | BASF SE (DE) | 2011-05-24 | — | — | US | disclosed |
| US-7947848-B2 | Coloured silsesquioxanes | BASF SE (DE) | 2011-05-24 | — | — | US | disclosed |
| US-20090296195-A1 | Coloured Particles for Electrophoretic Displays | BASF SE (DE) | 2009-12-03 | — | — | US | disclosed |
| US-20090296195-A1 | Coloured Particles for Electrophoretic Displays | BASF SE (DE) | 2009-12-03 | — | — | US | disclosed |
| US-20090203931-A1 | Coloured Silsesquioxanes | BASF SE (DE) | 2009-08-13 | — | — | US | disclosed |
| WO-2007147742-A1 | COLOURED SILSESQUIOXANES | CIBA HOLDING INC. (CH) | 2007-12-27 | — | — | WO | disclosed |
| EP-0721447-B1 | ANTHRACENE DERIVATIVES FOR USE AS ANTICANCER AGENT OR DYE | UNIV NAPIER (GB) | 1998-02-25 | — | — | EP | disclosed |
| EP-0721447-A1 | ANTHRACENE DERIVATIVES FOR USE AS ANTICANCER AGENT OR DYE | NAPIER UNIVERSITY VENTURES LIMITED (GB) | 1996-07-17 | — | — | EP | disclosed |
| WO-1995009149-A1 | ANTHRACENE DERIVATIVES FOR USE AS ANTICANCER AGENT OR DYE | NAPIER UNIVERSITY VENTURES LIMITED (GB) | 1995-04-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090296195-A1 | Coloured Particles for Electrophoretic Displays | RAB5IF, IK, AOX1 | MAPT 4267/4885MEN1 3454/4885KMT2A 3839/4885 |
| US-20090203931-A1 | Coloured Silsesquioxanes | CBX7, CD47, SFXN1 | MAPT 2448/4885MEN1 4570/4885KMT2A 2327/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.